Antabio
FranceEntry
2018
Hold
8yr
Status
Active
Who owns Antabio?
Antabio is currently owned by Turenne Groupe through Capital Santé 2 (2020 vintage), since 2018. Across its history, Antabio has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Turenne GroupeCapital Santé 2 · 2020 · Growth
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Irdi Capital-Investissement, Galia Gestion, iXO Private Equity and Turenne Groupe since 2017.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-held by Irdi Capital-Investissement, Galia Gestion, iXO Private Equity and Turenne Groupe since 2017.
Co-invest · 4 holders · 2017 · present
Galia GestionActive
2017 · present(9yr) · Galia Investissements III · 2013
Turenne GroupeActive
2018 · present(8yr) · Capital Santé 2 · 2020 · Growth
iXO Private EquityActive
2018 · present(8yr) · FIP APL 2015 · 2015 · Evergreen
More from Capital Santé 2
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
USTrack Antabio
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Antabio.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue